Luke McLaughlin: Haemophilia Care as a Matter of Global Health Equity
Luke McLaughlin, Founder of The Haemophilia Rights Project, shared World Federation of Hemophilia‘s post on LinkedIn, adding:
“The significance of this milestone should not be understated.
The advancement of medical treatments in Haemophilia can only be seen as revolutionary if they are equally distributed around the globe.
No human should be too expensive or inconvenient to treat. Cost should never be an excuse to disregard human rights.
I commend Armenia, World Federation of Hemophilia and the unilateral coalition of supporting states for highlighting treatment equity in Haemophilia at the highest international level.
Treatment should be a right for all people with Haemophilia and bleeding disorders.”
World Federation of Hemophilia (WFH) shared a post on LinkedIn:
“Today marks a historic milestone for the global Bleeding Disorders community.
The 79th World Health Assembly has adopted the resolution on ‘Global action to advance health equity for people with hemophilia and other bleeding disorders.’
This landmark adoption recognizes the urgent need to improve diagnosis, access to treatment, comprehensive care, and health equity for people living with bleeding disorders around the world.
It signals commitment by the WHO and Member States to advance these priorities.
Watch the address of Cesar Garrido, the WFH President, at the WHA79.
The World Federation of Hemophilia extends its sincere gratitude to Armenia for its leadership, as well as to all co-sponsoring Member States – in addition to all the partners, advocates, healthcare professionals, national member organizations, and community members whose collaboration helped make this possible, including over 100 organizations that joined the WFH’s Global Call for Health Equity for Bleeding Disorders.”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
May 25, 2026, 13:04Mohammad Ameen Ishqair: Blood Group Antigens as Emerging Biomarkers in Disease
-
May 25, 2026, 13:04Dhruvi Joshi: Reduced-Dose DOAC Therapy in Patients With Venous Thromboembolism
-
May 25, 2026, 12:33Laird Bruce de Graaf: The Most Compassionate Gift You Can Give
-
May 25, 2026, 12:30Dheri Lubis: Deeper Into Immunohematology Beyond Basic Blood Grouping
-
May 25, 2026, 11:20Abdul Mannan: Why Thalassaemia Is More Than Low Haemoglobin
-
May 25, 2026, 11:06Roberta Gualtierotti: Iron Is More Than a Hematologic Parameter
-
May 25, 2026, 11:03Divyaswathi Citla Sridhar: How Bone Health Is Impacted in Bleeding Disorders
-
May 25, 2026, 10:48Ama Ameyaw: Beginning My Research Journey in HIT and Platelet Immunology at the Wen Lab
-
May 25, 2026, 10:46Fredrick Chalinga: Negative DAT Does Not Mean No Hemolysis